FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1551230608> ?p ?o ?g. }

• W1551230608 endingPage "284" @default.
• W1551230608 startingPage "273" @default.
• W1551230608 abstract "Abstract A method is described for the isolation of glyceraldehyde 3-phosphate dehydrogenase from rabbit liver. The enzyme has been crystallized as the NAD complex and its chemical and physical properties have been compared with those of the muscle enzyme. The kinetics of the reversible reaction catalyzed by the dehydrogenases is sensitive to temperature and ionic strength and has been examined at 37°, pH 7.4, in a solvent of ionic strength 0.1. Under these conditions the outstanding new feature of the reverse reaction, the reductive dephosphorylation of 3-phosphoglyceroyl phosphate, is the positive cooperativity of the response of both enzymes to concentration increments of the acyl phosphate and the increase in this cooperativity as a function of concentration of the cosubstrate, NADH. At low concentrations of the acyl phosphate, the reduced coenzyme exerts an inhibitory function which is abolished by high concentrations of acyl phosphate or by low concentrations of NAD acting as a heterotropic effector. The same concentrations of NAD which activate at low acyl phosphate concentration inhibit at high concentrations of the 3-carbon substrate by competing with NADH. Activation of the reaction by NAD involves a transition of the acyl phosphate saturation function from a sigmoidal to the hyperbolic form and hence sensitizes the enzyme to lower concentrations of acyl phosphate. The substrate inhibition by NADH and the activation by NAD may be accounted for by the binding of the nucleotides to catalytic sites of the tetrameric protein that are not occupied by the acyl enzyme intermediate. Although the competitive advantage in binding to the apoprotein strongly favors NAD over NADH, the competition under reaction conditions tends to be equalized at nonacylated sites of the acylated protein and is drastically reversed at the acylated sites. Thus at kinetic saturation levels of the acyl phosphate Knadh remains in the 10-µm range, but half-maximal inhibition by NAD occurs at concentrations of the latter that are in excess of 1000 µm. These properties involve both ligandinduced conformational transitions of the protein and a local steric effect of the acyl group that interferes with the binding of the oxidized but not the reduced form of the pyridine nucleotide. In the forward or oxidative phosphorylation reaction the reciprocal kinetic plots are entirely linear except under conditions of product inhibition by NADH. The preferential binding of NADH at an acylated site is not strongly expressed in the inhibition by added NADH because such sites are already occupied by product NADH that is released subsequent to the rate-limiting acyl group transfer from enzyme to orthophosphate ion. The acyl phosphate is a strong inhibitor of the forward reaction, noncompetitive with NAD and strictly competitive with aldehyde. Intracellularly, the enzyme always operates in the presence of high concentrations of NAD which are required to provide the driving force for the energy-conserving reaction. Functional reversibility, under the adverse substrate concentration distributions in the aerobic hepatocyte, is maintained by regulatory effects of NAD binding which promote the reaction of extremely low concentrations of acyl phosphate, and by the differential effects of acylation of the protein which allow access of substrate NADH and at the same time eliminate a prohibitive inhibition by the high concentrations of NAD. The catalytic properties of the liver and muscle enzyme are qualitatively similar but exhibit some quantitative differences that would favor the more diversified metabolic requirements of liver. However, no definitive structural differences have been identified." @default.
• W1551230608 created "2016-06-24" @default.
• W1551230608 creator A5016136321 @default.
• W1551230608 creator A5029689588 @default.
• W1551230608 date "1972-01-01" @default.
• W1551230608 modified "2023-09-30" @default.
• W1551230608 title "The Glyceraldehyde 3-Phosphate Dehydrogenases of Liver and Muscle" @default.
• W1551230608 cites W106577432 @default.
• W1551230608 cites W128670986 @default.
• W1551230608 cites W128699936 @default.
• W1551230608 cites W1524786741 @default.
• W1551230608 cites W1567610244 @default.
• W1551230608 cites W1571793851 @default.
• W1551230608 cites W1573120040 @default.
• W1551230608 cites W1574569511 @default.
• W1551230608 cites W1576127641 @default.
• W1551230608 cites W1580386020 @default.
• W1551230608 cites W161663416 @default.
• W1551230608 cites W1944498153 @default.
• W1551230608 cites W194987105 @default.
• W1551230608 cites W1967152653 @default.
• W1551230608 cites W1991706057 @default.
• W1551230608 cites W1997958669 @default.
• W1551230608 cites W1998093640 @default.
• W1551230608 cites W2006370393 @default.
• W1551230608 cites W2008437533 @default.
• W1551230608 cites W2009652285 @default.
• W1551230608 cites W2012644269 @default.
• W1551230608 cites W2035969515 @default.
• W1551230608 cites W2046938695 @default.
• W1551230608 cites W2054423281 @default.
• W1551230608 cites W2054472939 @default.
• W1551230608 cites W2075760809 @default.
• W1551230608 cites W2085474307 @default.
• W1551230608 cites W2312506344 @default.
• W1551230608 cites W2410327251 @default.
• W1551230608 cites W2413573908 @default.
• W1551230608 cites W2417728110 @default.
• W1551230608 cites W2470154218 @default.
• W1551230608 cites W3143050058 @default.
• W1551230608 cites W37730202 @default.
• W1551230608 cites W39635534 @default.
• W1551230608 cites W98494768 @default.
• W1551230608 doi "https://doi.org/10.1016/s0021-9258(19)45786-4" @default.
• W1551230608 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/4336365" @default.
• W1551230608 hasPublicationYear "1972" @default.
• W1551230608 type Work @default.
• W1551230608 sameAs 1551230608 @default.
• W1551230608 citedByCount "58" @default.
• W1551230608 countsByYear W15512306082012 @default.
• W1551230608 countsByYear W15512306082013 @default.
• W1551230608 countsByYear W15512306082023 @default.
• W1551230608 crossrefType "journal-article" @default.
• W1551230608 hasAuthorship W1551230608A5016136321 @default.
• W1551230608 hasAuthorship W1551230608A5029689588 @default.
• W1551230608 hasBestOaLocation W15512306081 @default.
• W1551230608 hasConcept C134792803 @default.
• W1551230608 hasConcept C181199279 @default.
• W1551230608 hasConcept C185592680 @default.
• W1551230608 hasConcept C2776317432 @default.
• W1551230608 hasConcept C2777132085 @default.
• W1551230608 hasConcept C55493867 @default.
• W1551230608 hasConceptScore W1551230608C134792803 @default.
• W1551230608 hasConceptScore W1551230608C181199279 @default.
• W1551230608 hasConceptScore W1551230608C185592680 @default.
• W1551230608 hasConceptScore W1551230608C2776317432 @default.
• W1551230608 hasConceptScore W1551230608C2777132085 @default.
• W1551230608 hasConceptScore W1551230608C55493867 @default.
• W1551230608 hasIssue "1" @default.
• W1551230608 hasLocation W15512306081 @default.
• W1551230608 hasOpenAccess W1551230608 @default.
• W1551230608 hasPrimaryLocation W15512306081 @default.
• W1551230608 hasRelatedWork W1857102957 @default.
• W1551230608 hasRelatedWork W1987470712 @default.
• W1551230608 hasRelatedWork W1988064189 @default.
• W1551230608 hasRelatedWork W2030427530 @default.
• W1551230608 hasRelatedWork W2078646031 @default.
• W1551230608 hasRelatedWork W2154133864 @default.
• W1551230608 hasRelatedWork W2413625052 @default.
• W1551230608 hasRelatedWork W2472842241 @default.
• W1551230608 hasRelatedWork W2988787281 @default.
• W1551230608 hasRelatedWork W4311662192 @default.
• W1551230608 hasVolume "247" @default.
• W1551230608 isParatext "false" @default.
• W1551230608 isRetracted "false" @default.
• W1551230608 magId "1551230608" @default.
• W1551230608 workType "article" @default.